2m 2m 2m 2m 2m 2m 2m
ATTOVIA THERAP (ATTO)
NASDAQ
$17.17-$0.005 (-0.03%)
Price as of Oct 02, 2026 7:30 PM EDT- $783.8MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
ATTOVIA THERAP (ATTO)
$17.17-$0.005 (-0.03%)
ATTO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.17 | ||
Change | -$0.62 (-3.49%) | ||
Open | $17.73 | ||
High | $18.50 | ||
Low | $17.00 | ||
Previous Close | $17.79 | ||
Volume | 348,657 | ||
30-Day Average Volume | 411,399 | ||
1-Week Change | -3.43% | ||
1-Month Change | -25.77% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 45.7M | ||
Total Assets | $128.3M | ||
Market Cap | $783.8M | ||
Enterprise Value | $751.0M | ||
Period: QTR TTM FY | |||
Revenue | $450,000.00 | ||
Net Income | -$20.7M | ||
Free Cash Flow | N/A | ||
EBIT | -$20.7M | ||
EBITDA | -$20.5M | ||
Net Working Capital | N/A | ||
EPS | -$4.88 | ||
Enterprise Value/EBITDA | -37 | ||
Enterprise Value/Revenue | 1,669 | ||
P/B | -5 | ||
P/E | -4 | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 11/09/2017 | ||
Last Split Factor | 1 : 5.0270904666729 | ||
Last Split Date | 07/30/2020 | ||